A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)

Protocol No
PULM-UNITED-ROR-PH-303
Phase
III
Summary

This project is being done to evaluate the long term efficacy and safety of Ralinepag in the treatment of pulmonary arterial hypertension.

Description
Ralinepag in Subjects with PAH via an Open-label Extension
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Lungs and Breathing, Pulmonary Arterial Hypertension
ClinicalTrials.gov
go to website